BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 37494773)

  • 21. Luteolin ameliorates necroptosis in Glucocorticoid-induced osteonecrosis of the femoral head via RIPK1/RIPK3/MLKL pathway based on network pharmacology analysis.
    Xu X; Fan X; Wu X; Xia R; Liang J; Gao F; Shu J; Yang M; Sun W
    Biochem Biophys Res Commun; 2023 Jun; 661():108-118. PubMed ID: 37099894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RIPK1-RIPK3-MLKL-Associated Necroptosis Drives
    Barbosa LA; Fiuza PP; Borges LJ; Rolim FA; Andrade MB; Luz NF; Quintela-Carvalho G; Lima JB; Almeida RP; Chan FK; Bozza MT; Borges VM; Prates DB
    Front Immunol; 2018; 9():1818. PubMed ID: 30154785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenytoin inhibits necroptosis.
    von Mässenhausen A; Tonnus W; Himmerkus N; Parmentier S; Saleh D; Rodriguez D; Ousingsawat J; Ang RL; Weinberg JM; Sanz AB; Ortiz A; Zierleyn A; Becker JU; Baratte B; Desban N; Bach S; Schiessl IM; Nogusa S; Balachandran S; Anders HJ; Ting AT; Bleich M; Degterev A; Kunzelmann K; Bornstein SR; Green DR; Hugo C; Linkermann A
    Cell Death Dis; 2018 Mar; 9(3):359. PubMed ID: 29500402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High glucose-induced apoptosis and necroptosis in podocytes is regulated by UCHL1 via RIPK1/RIPK3 pathway.
    Xu Y; Gao H; Hu Y; Fang Y; Qi C; Huang J; Cai X; Wu H; Ding X; Zhang Z
    Exp Cell Res; 2019 Sep; 382(2):111463. PubMed ID: 31247189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury.
    Newton K; Dugger DL; Maltzman A; Greve JM; Hedehus M; Martin-McNulty B; Carano RA; Cao TC; van Bruggen N; Bernstein L; Lee WP; Wu X; DeVoss J; Zhang J; Jeet S; Peng I; McKenzie BS; Roose-Girma M; Caplazi P; Diehl L; Webster JD; Vucic D
    Cell Death Differ; 2016 Sep; 23(9):1565-76. PubMed ID: 27177019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Key necroptotic proteins are required for Smac mimetic-mediated sensitization of cholangiocarcinoma cells to TNF-α and chemotherapeutic gemcitabine-induced necroptosis.
    Akara-Amornthum P; Lomphithak T; Choksi S; Tohtong R; Jitkaew S
    PLoS One; 2020; 15(1):e0227454. PubMed ID: 31914150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RIPK3-Dependent Necroptosis Activates MCP-1-Mediated Inflammation in Mice after Intracerebral Hemorrhage.
    Huang S; Hu W; Rao D; Wu X; Bai Q; Wang J; Chu Z; Xu Y
    J Stroke Cerebrovasc Dis; 2022 Jan; 31(1):106213. PubMed ID: 34837868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Lck inhibitor, AMG-47a, blocks necroptosis and implicates RIPK1 in signalling downstream of MLKL.
    Jacobsen AV; Pierotti CL; Lowes KN; Au AE; Zhang Y; Etemadi N; Fitzgibbon C; Kersten WJA; Samson AL; van Delft MF; Huang DCS; Sabroux HJ; Lessene G; Silke J; Murphy JM
    Cell Death Dis; 2022 Apr; 13(4):291. PubMed ID: 35365636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RIPK1 inhibits ZBP1-driven necroptosis during development.
    Newton K; Wickliffe KE; Maltzman A; Dugger DL; Strasser A; Pham VC; Lill JR; Roose-Girma M; Warming S; Solon M; Ngu H; Webster JD; Dixit VM
    Nature; 2016 Dec; 540(7631):129-133. PubMed ID: 27819682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A toolbox for imaging RIPK1, RIPK3, and MLKL in mouse and human cells.
    Samson AL; Fitzgibbon C; Patel KM; Hildebrand JM; Whitehead LW; Rimes JS; Jacobsen AV; Horne CR; Gavin XJ; Young SN; Rogers KL; Hawkins ED; Murphy JM
    Cell Death Differ; 2021 Jul; 28(7):2126-2144. PubMed ID: 33589776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RIPK1/RIPK3/MLKL-mediated necroptosis contributes to compression-induced rat nucleus pulposus cells death.
    Chen S; Lv X; Hu B; Shao Z; Wang B; Ma K; Lin H; Cui M
    Apoptosis; 2017 May; 22(5):626-638. PubMed ID: 28289909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced RIPK3 kinase activity-dependent lytic cell death in M1 but not M2 macrophages.
    Hao Q; Kundu S; Kleam J; Zhao ZJ; Idell S; Tang H
    Mol Immunol; 2021 Jan; 129():86-93. PubMed ID: 33221042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Casein kinase-1γ1 and 3 stimulate tumor necrosis factor-induced necroptosis through RIPK3.
    Lee SY; Kim H; Li CM; Kang J; Najafov A; Jung M; Kang S; Wang S; Yuan J; Jung YK
    Cell Death Dis; 2019 Dec; 10(12):923. PubMed ID: 31801942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Jujuboside B promotes the death of acute leukemia cell in a RIPK1/RIPK3/MLKL pathway-dependent manner.
    Jia MM; Li YQ; Xu KQ; Zhang YY; Tan SM; Zhang Q; Peng J; Luo XJ
    Eur J Pharmacol; 2020 Jun; 876():173041. PubMed ID: 32142769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Bcr-Abl inhibitor GNF-7 inhibits necroptosis and ameliorates acute kidney injury by targeting RIPK1 and RIPK3 kinases.
    Qin X; Hu L; Shi SN; Chen X; Zhuang C; Zhang W; Jitkaew S; Pang X; Yu J; Tan YX; Wang HY; Cai Z
    Biochem Pharmacol; 2020 Jul; 177():113947. PubMed ID: 32247850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MLKL and CaMKII Are Involved in RIPK3-Mediated Smooth Muscle Cell Necroptosis.
    Zhou T; DeRoo E; Yang H; Stranz A; Wang Q; Ginnan R; Singer HA; Liu B
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Caspase-8 auto-cleavage regulates programmed cell death and collaborates with RIPK3/MLKL to prevent lymphopenia.
    Li X; Li F; Zhang X; Zhang H; Zhao Q; Li M; Wu X; Wang L; Liu J; Wu X; Ou Y; Xing M; Zhang Y; Deng J; Wang X; Luo Y; Li J; Zhao Y; Zhang H
    Cell Death Differ; 2022 Aug; 29(8):1500-1512. PubMed ID: 35064213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RIPK1 both positively and negatively regulates RIPK3 oligomerization and necroptosis.
    Orozco S; Yatim N; Werner MR; Tran H; Gunja SY; Tait SW; Albert ML; Green DR; Oberst A
    Cell Death Differ; 2014 Oct; 21(10):1511-21. PubMed ID: 24902904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RIPK3 inhibitor-AZD5423 alleviates acute kidney injury by inhibiting necroptosis and inflammation.
    Xu CH; Wang JN; Suo XG; Ji ML; He XY; Chen X; Zhu S; He Y; Xie SS; Li C; Dong ZH; Chen Y; Ni WJ; Feng XW; Liu MM; Jin J; Li Z; Meng XM
    Int Immunopharmacol; 2022 Nov; 112():109262. PubMed ID: 36166972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of RIPK3-mediated phosphorylation of the activation loop of MLKL during necroptosis.
    Rodriguez DA; Weinlich R; Brown S; Guy C; Fitzgerald P; Dillon CP; Oberst A; Quarato G; Low J; Cripps JG; Chen T; Green DR
    Cell Death Differ; 2016 Jan; 23(1):76-88. PubMed ID: 26024392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.